LON:COG Cambridge Cognition (COG) Share Price, News & Analysis GBX 32.77 +1.27 (+4.03%) As of 07:29 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesBuy This Stock About Cambridge Cognition Stock (LON:COG) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Cambridge Cognition alerts:Sign Up Key Stats Today's Range 30▼ 3350-Day Range 31.25▼ 3952-Week Range 23.90▼ 45Volume13,444 shsAverage Volume34,644 shsMarket Capitalization£17.64 millionP/E RatioN/ADividend YieldN/APrice TargetGBX 56Consensus RatingBuy Company Overview Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency. It also provides CANTAB Connect Research, a proprietary platform that provides insights into behaviours, underlying brain circuits, and measurement of digital cognitive biomarkers; CANTAB Mobile, a touchscreen assessment of memory, mood, and functional status to detect the earliest signs of clinically relevant memory problems; CANTAB Insight to assess cognitive health; and CANTAB BrainHealth for assessing workplace wellbeing. In addition, the company offers electronic questionnaires and scales, a digital bespoke questionnaire; NeuroVocalix, a voice analysis platform to analyze voice to assess neurological change; cognition kit, a high frequency testing kit to detect changes over time and day-to-day cognition with short regular tests using patients' own devices. Cambridge Cognition Holdings Plc was incorporated in 2012 and is based in Cambridge, the United Kingdom. Read More Receive COG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cambridge Cognition and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. COG Stock News HeadlinesCambridge Cognition teams up with smart ring firm ŌURA for brain health studyMay 29, 2026 | uk.finance.yahoo.comCambridge Cognition Holdings PLC COGMay 14, 2026 | morningstar.comMYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.July 17 at 1:00 AM | Profits Run (Ad)Cavendish sees 100% upside in Cambridge Cognition as order book rebuild gathers paceMay 14, 2026 | uk.finance.yahoo.comCambridge Cognition Holdings PLC 1M7April 8, 2026 | morningstar.comMCambridge Cognition says Monument Therapeutics has dosed first patient in psychosis prevention trialMarch 11, 2026 | uk.finance.yahoo.comCambridge Cognition’s India deal could be a game changerFebruary 16, 2026 | sg.finance.yahoo.comCambridge Cognition ties up with India’s Ivory to roll out early cognitive screeningFebruary 16, 2026 | uk.finance.yahoo.comSee More Headlines COG Stock Analysis - Frequently Asked Questions How have COG shares performed this year? Cambridge Cognition's stock was trading at GBX 27.22 at the start of the year. Since then, COG stock has increased by 21.2% and is now trading at GBX 33. How were Cambridge Cognition's earnings last quarter? Cambridge Cognition Holdings Plc (LON:COG) released its quarterly earnings results on Monday, April, 13th. The company reported ($3.90) earnings per share (EPS) for the quarter. The firm had revenue of $9.40 million for the quarter. Cambridge Cognition had a negative trailing twelve-month return on equity of 62.89% and a negative net margin of 17.82%. How do I buy shares of Cambridge Cognition? Shares of COG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Cambridge Cognition own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cambridge Cognition investors own include Interserve (IRV), Tullow Oil (TLW), AMC Entertainment (AMC), Antofagasta (ANTO), Aviva (AV), Alibaba Group (BABA) and B&M European Value Retail (BME). Company Calendar Last Earnings4/13/2026Today7/17/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Health Information Services Sub-IndustryN/A Current SymbolLON:COG CIKN/A Webwww.cambridgecognition.com Phone44 1223 810 700FaxN/AEmployees80Year FoundedN/APrice Target and Rating Average Price Target for Cambridge CognitionGBX 56 High Price TargetGBX 56 Low Price TargetGBX 56 Potential Upside/Downside+70.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Trailing Twelve Months)GBX (3.90) Trailing P/E RatioN/A Forward P/E Ratio31.84 P/E GrowthN/ANet Income-£1.58 million Net Margins-17.82% Pretax MarginN/A Return on Equity-62.89% Return on Assets-0.30% Debt Debt-to-Equity Ratio29.16 Current Ratio0.40 Quick Ratio0.96 Sales & Book Value Annual Sales£9.40 million Price / Sales1.88 Cash FlowGBX 7.61 per share Price / Cash Flow4.31 Book ValueGBX 7.27 per share Price / Book4.51Miscellaneous Outstanding Shares53,824,000Free FloatN/AMarket Cap£17.64 million OptionableNot Optionable Beta0.80 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (LON:COG) was last updated on 7/17/2026 by MarketBeat.com Staff. From Our PartnersLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredElon’s new "tollbooth"The SpaceX IPO was valued at $1.75 trillion. But one analyst says fighting over those shares may be the wrong ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cambridge Cognition Holdings Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Cambridge Cognition With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free COG Stock Alerts